These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17020980)

  • 1. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.
    Chang GC; Liu KJ; Hsieh CL; Hu TS; Charoenfuprasert S; Liu HK; Luh KT; Hsu LH; Wu CW; Ting CC; Chen CY; Chen KC; Yang TY; Chou TY; Wang WH; Whang-Peng J; Shih NY
    Clin Cancer Res; 2006 Oct; 12(19):5746-54. PubMed ID: 17020980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
    Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW
    Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of secreted proteins of non-small cell lung cancer.
    Huang LJ; Chen SX; Luo WJ; Jiang HH; Zhang PF; Yi H
    Ai Zheng; 2006 Nov; 25(11):1361-7. PubMed ID: 17094902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer.
    Zhang S; Qiu X; Gu Y; Wang E
    Lung Cancer; 2008 Dec; 62(3):295-301. PubMed ID: 18571765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior.
    Chang YS; Wu W; Walsh G; Hong WK; Mao L
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3641-4. PubMed ID: 14506152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
    Hsu CP; Shen GH; Ko JL
    Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron specific enolase tissue expression as a prognostic factor in advanced non small cell lung cancer.
    Petrovic M; Tomic I; Plavec G; Ilic S; Ilic N; Baskic D
    J BUON; 2008; 13(1):93-6. PubMed ID: 18404793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
    Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
    Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction.
    Tsai ST; Chien IH; Shen WH; Kuo YZ; Jin YT; Wong TY; Hsiao JR; Wang HP; Shih NY; Wu LW
    Eur J Cancer; 2010 Jun; 46(9):1712-23. PubMed ID: 20435467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
    Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
    Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome.
    Wang CL; Wang CI; Liao PC; Chen CD; Liang Y; Chuang WY; Tsai YH; Chen HC; Chang YS; Yu JS; Wu CC; Yu CJ
    J Proteome Res; 2009 Oct; 8(10):4428-40. PubMed ID: 19655816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
    Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
    Yu SP; Xiong YY; Tian SF
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
    J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic utility of carcinoembryonic antigen, neuron-specific enolase and squamous cell carcinoma antigen in malignant pleural effusion].
    Sánchez de Cos Escuín J; López Parra S; Disdier Vicente C; Martín Vicente MJ; Masa Jiménez JF; Domínguez Retortillo C
    An Med Interna; 1996 Aug; 13(8):369-73. PubMed ID: 8983362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
    Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.